{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T12:06:41Z","timestamp":1788264401244,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1124\/dmd.122.001037","type":"journal-article","created":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T20:10:12Z","timestamp":1667160612000},"page":"17-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Quantitative Evaluation of the Contribution of Each Aldo-Keto Reductase and Short-Chain Dehydrogenase\/Reductase Isoform to Reduction Reactions of Compounds Containing a Ketone Group in the Human Liver"],"prefix":"10.1016","volume":"51","author":[{"given":"Hiroyuki","family":"Ichida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuki","family":"Fukami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keito","family":"Amai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Mishiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiori","family":"Takano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Obuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.122.001037_bib1","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.dmpk.2020.08.004","article-title":"Quantitative analysis of mRNA expression levels of aldo-keto reductase and short-chain dehydrogenase\/reductase isoforms in human livers","volume":"35","author":"Amai","year":"2020","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/dmd.122.001037_bib4","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"key":"10.1124\/dmd.122.001037_bib5","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0006-2952(99)00319-6","article-title":"High-affinity stereoselective reduction of the enantiomers of ketotifen and of ketonic nortriptyline metabolites by aldo-keto reductases from human liver","volume":"59","author":"Breyer-Pfaff","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.122.001037_bib6","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1211\/0022357045020","article-title":"Carbonyl reduction of naltrexone and dolasetron by oxidoreductases isolated from human liver cytosol","volume":"56","author":"Breyer-Pfaff","year":"2004","journal-title":"J Pharm Pharmacol"},{"issue":"2, Suppl","key":"10.1124\/dmd.122.001037_bib7","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/S0376-8716(03)00058-9","article-title":"Pharmacokinetics of the combination tablet of buprenorphine and naloxone","volume":"70","author":"Chiang","year":"2003","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/dmd.122.001037_bib8","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1124\/dmd.115.063107","article-title":"Metabolism of bupropion by carbonyl reductases in liver and intestine","volume":"43","author":"Connarn","year":"2015","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001037_bib9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0065-2490(05)80006-1","article-title":"Xenobiotic-metabolizing human cells as tools for pharmacological and toxicological research","volume":"26","author":"Crespi","year":"1995","journal-title":"Adv Drug Res"},{"key":"10.1124\/dmd.122.001037_bib10","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1124\/dmd.31.5.631","article-title":"Identification of metabolic pathways involved in the biotransformation of tolperisone by human microsomal enzymes","volume":"31","author":"Dalmadi","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001037_bib11","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1111\/epi.12242","article-title":"Pharmacokinetics and tolerability of eslicarbazepine acetate and oxcarbazepine at steady state in healthy volunteers","volume":"54","author":"Elger","year":"2013","journal-title":"Epilepsia"},{"key":"10.1124\/dmd.122.001037_bib12","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/0006-2952(92)90117-2","article-title":"Stereospecific reduction of haloperidol in human tissues","volume":"44","author":"Eyles","year":"1992","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.122.001037_bib13","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1124\/dmd.110.034454","article-title":"In vitro evaluation of inhibitory effects of antidiabetic and antihyperlipidemic drugs on human carboxylesterase activities","volume":"38","author":"Fukami","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001037_bib14","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1146\/annurev-pharmtox-052220-105907","article-title":"Non-P450 Drug-metabolizing enzymes: contribution to drug disposition, toxicity, and development","volume":"62","author":"Fukami","year":"2022","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/dmd.122.001037_bib15","first-page":"5158","article-title":"Human carbonyl reductase overexpression in the heart advances the development of doxorubicin-induced cardiotoxicity in transgenic mice","volume":"60","author":"Forrest","year":"2000","journal-title":"Cancer Res"},{"key":"10.1124\/dmd.122.001037_bib42","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1124\/dmd.121.000513","article-title":"Differences in Hydrolase Activities in the Liver and Small Intestine between Marmosets and Humans","volume":"49","author":"Honda","year":"2021","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001037_bib17","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0009-2797(00)00236-2","article-title":"Novel enzymological profiles of human 11\u03b2-hydroxysteroid dehydrogenase type 1","volume":"130-132","author":"Hult","year":"2001","journal-title":"Chem Biol Interact"},{"key":"10.1124\/dmd.122.001037_bib18","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0090-9556(25)08764-1","article-title":"Haloperidol reductase in human and guinea pig livers","volume":"17","author":"Inaba","year":"1989","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001037_bib19","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.steroids.2005.12.002","article-title":"Molecular docking simulations of steroid substrates into human cytosolic hydroxysteroid dehydrogenases (AKR1C1 and AKR1C2): insights into positional and stereochemical preferences","volume":"71","author":"Jin","year":"2006","journal-title":"Steroids"},{"key":"10.1124\/dmd.122.001037_bib20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4333\/KPS.2011.41.2.117","article-title":"Bioequivalence of hana loxoprofen sodium tablet to dongwha loxonin\u00ae tablet (loxoprofen sodium 60 mg)","volume":"41","author":"Kang","year":"2011","journal-title":"J Pharm Investig"},{"key":"10.1124\/dmd.122.001037_bib21","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1124\/dmd.108.022251","article-title":"Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver","volume":"36","author":"Kassner","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001037_bib22","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0090-9556(25)08384-9","article-title":"Carbonyl reductase activity for acetohexamide in human erythrocytes","volume":"22","author":"Kishimoto","year":"1994","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001037_bib24","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/S0090-9556(25)08447-8","article-title":"Metabolism of lisofylline and pentoxifylline in human liver microsomes and cytosol","volume":"24","author":"Lillibridge","year":"1996","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001037_bib26","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.cbi.2014.07.005","article-title":"The role of carbonyl reducing enzymes in oxcarbazepine in\u2009vitro metabolism in man","volume":"220","author":"Mal\u00e1tkov\u00e1","year":"2014","journal-title":"Chem Biol Interact"},{"key":"10.1124\/dmd.122.001037_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2133\/dmpk.21.1","article-title":"Multiplicity of mammalian reductases for xenobiotic carbonyl compounds","volume":"21","author":"Matsunaga","year":"2006","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/dmd.122.001037_bib28","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1124\/dmd.113.052936","article-title":"Formation of threohydrobupropion from bupropion is dependent on 11\u03b2-hydroxysteroid dehydrogenase 1","volume":"41","author":"Meyer","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001037_bib29","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.bcp.2013.10.001","article-title":"N-Glycosylation during translation is essential for human arylacetamide deacetylase enzyme activity","volume":"87","author":"Muta","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.122.001037_bib30","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/chir.10121","article-title":"Stereoselective metabolism of pentoxifylline in\u2009vitro and in\u2009vivo in humans","volume":"14","author":"Nicklasson","year":"2002","journal-title":"Chirality"},{"key":"10.1124\/dmd.122.001037_bib32","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0006-2952(95)00124-I","article-title":"Reduction of drug ketones by dihydrodiol dehydrogenases, carbonyl reductase and aldehyde reductase of human liver","volume":"50","author":"Ohara","year":"1995","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.122.001037_bib33","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1096\/fasebj.4.13.2210154","article-title":"Doxorubicin cardiotoxicity: analysis of prevailing hypotheses","volume":"4","author":"Olson","year":"1990","journal-title":"FASEB J"},{"key":"10.1124\/dmd.122.001037_bib34","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cbi.2012.11.009","article-title":"Classification and nomenclature of the superfamily of short-chain dehydrogenases\/reductases (SDRs)","volume":"202","author":"Persson","year":"2013","journal-title":"Chem Biol Interact"},{"key":"10.1124\/dmd.122.001037_bib37","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cbi.2010.12.016","article-title":"Anthracyclines and their metabolism in human liver microsomes and the participation of the new microsomal carbonyl reductase","volume":"191","author":"Skarka","year":"2011","journal-title":"Chem Biol Interact"},{"key":"10.1124\/dmd.122.001037_bib38","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1124\/dmd.32.7.762","article-title":"Bioactivation of capecitabine in human liver: involvement of the cytosolic enzyme on 5\u2032-deoxy-5-fluorocytidine formation","volume":"32","author":"Tabata","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001037_bib39","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0014-5793(93)80719-B","article-title":"Autocatalytic modification of human carbonyl reductase by 2-oxocarboxylic acids","volume":"335","author":"Wermuth","year":"1993","journal-title":"FEBS Lett"},{"key":"10.1124\/dmd.122.001037_bib41","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0009-2797(00)00149-6","article-title":"Cytochrome P450 2E1 is the primary enzyme responsible for low-dose carbon tetrachloride metabolism in human liver microsomes","volume":"125","author":"Zangar","year":"2000","journal-title":"Chem Biol Interact"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624009152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624009152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.122.001037","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T08:58:27Z","timestamp":1739955507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624009152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0090955624009152"],"URL":"https:\/\/doi.org\/10.1124\/dmd.122.001037","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantitative Evaluation of the Contribution of Each Aldo-Keto Reductase and Short-Chain Dehydrogenase\/Reductase Isoform to Reduction Reactions of Compounds Containing a Ketone Group in the Human Liver","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.122.001037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}